Feb 26 10:30 ET RBC Capital Markets Healthcare Conf
Feb 27 9:35 ET Citi Global Health Care Conf Immunotherapy panel
1H13 Astellas Transvax Program Initiation of Phase 3 HCT trial
1H13 Phase 2 SOT trial to follow
Mid 2013 Top-Line data from Allovectin Phase 3 trial
More upcoming events
Cowen and Company 33rd Annual Health Care Conference (Boston, March 4-6) on Wednesday, March 6, at 8:00 a.m. ET.
25th Annual ROTH Conference (Dana Point, CA, March 17-20) on Tuesday, March 19, at 4:30 p.m. PT.
Continuing news from Astellas
News of dengue vaccine with Vaxfectin adjuvant
HSV trial news
Allovectin announcement from data sweep?